错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease

  • Lea Lemaitre,
  • Nia Adeniji,
  • Akanksha Suresh,
  • Reshma Reguram,
  • Josephine Zhang,
  • Jangho Park,
  • Amit Reddy,
  • Alexandro E. Trevino,
  • Aaron T. Mayer,
  • Anja Deutzmann,
  • Aida S. Hansen,
  • Ling Tong,
  • Vinodhini Arjunan,
  • Neeraja Kambham,
  • Brendan C. Visser,
  • Monica M. Dua,
  • C. Andrew Bonham,
  • Nishita Kothary,
  • H. Blaize D’Angio,
  • Ryan Preska,
  • Yanay Rosen,
  • James Zou,
  • Vivek Charu,
  • Dean W. Felsher,
  • Renumathy Dhanasekaran

摘要

Hepatocellular carcinoma (HCC) frequently recurs from minimal residual disease (MRD), which persists after therapy. Here, we identified mechanisms of persistence of residual tumor cells using post-chemoembolization human HCC (n = 108 patients, 1.07 million cells) and a transgenic mouse model of MRD. Through single-cell high-plex cytometric imaging, we identified a spatial neighborhood within which PD-L1 + M2-like macrophages interact with stem-like tumor cells, correlating with CD8+ T cell exhaustion and poor survival. Further, through spatial transcriptomics of residual HCC, we showed that macrophage-derived TGFβ1 mediates the persistence of stem-like tumor cells. Last, we demonstrate that combined blockade of Pdl1 and Tgfβ excluded immunosuppressive macrophages, recruited activated CD8+ T cells and eliminated residual stem-like tumor cells in two mouse models: a transgenic model of MRD and a syngeneic orthotopic model of doxorubicin-resistant HCC. Thus, our spatial analyses reveal that PD-L1+ macrophages sustain MRD by activating the TGFβ pathway in stem-like cancer cells and targeting this interaction may prevent HCC recurrence from MRD.